Wird geladen...
Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1
Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c‐NFs) and promote growth of pre‐existing c‐NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate.
Gespeichert in:
| Veröffentlicht in: | Clin Case Rep |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7669387/ https://ncbi.nlm.nih.gov/pubmed/33235741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3071 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|